triamcinolone acetonide has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katunuma, N; Kido, H; Tomihara, Y | 1 |
| Burton, AF; Turnell, RW | 1 |
| Katunuma, N; Kido, H; Ohsawa, N; Tomihara, Y; Watanabe, I | 1 |
3 other study(ies) available for triamcinolone acetonide and Leukemia L 1210
| Article | Year |
|---|---|
Growth inhibition of lymphoblast leukemia cells by amplifying factors of glucocorticoid actions.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Leukemia L1210; Leukemia L5178; Leukemia, Experimental; Male; Mice; Nucleotides; Proteus mirabilis; Triamcinolone Acetonide | 1980 |
Glucocorticoid receptors and lymphocytolysis in normal and neoplastic lymphocytes.
Topics: Animals; Binding Sites; Carnitine; Cell Nucleus; Drug Resistance; Fatty Acids, Nonesterified; Female; Hydrocortisone; Leukemia L1210; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred Strains; Microscopy, Electron; Neoplasms, Experimental; Protein Binding; Receptors, Cell Surface; T-Lymphocytes; Temperature; Thymus Gland; Triamcinolone Acetonide | 1975 |
Amplification of growth inhibition by glucocorticoid on L5178Y and L1210 lymphoblasts in vivo.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Cell Division; Drug Synergism; Growth Inhibitors; Leukemia L1210; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Proteus mirabilis; Triamcinolone Acetonide | 1979 |